Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 30

Sort by

Sort Order Select

Journal Articles

Dasatinib Versus Imatinib in Patients (Pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Who Have Not Achieved an Optimal Response to 3 Months of Imatinib Therapy: Dascern

Jorge E. Cortes, MD, Qian Jiang, MD, Jianxiang Wang, MD, Jianyu Weng, MD, Huanling Zhu, MD, Liu Xiaoli, MD, Andreas Hochhaus, MD, Dong-Wook Kim, MD PhD, Jerald Radich, MD, Michael R. Savona, MD, Patricia Martin Regueira, MD, Oumar Sy, PhD, Renuka Gurnani, BA, Giuseppe Saglio

Blood (2018) 132 (Supplement 1): 788.

https://doi.org/10.1182/blood-2018-99-111978

Published: 2018

Journal Articles

Compared the Effect of Mitroxantrone ( MA) with Idarubicine (IA) for Acute Myeloid Leukemia Induction Therapy

Peilong Lai, Mingyan Wu, Minming Li, Chengxin Deng, Zesheng Lu, Chenwei Luo, Xin Huang, Pengjun Liao, Lisi Huang, Ping Wu, Wang Yulian, Changchun Wan, Wei Ling, Liye Zhong, Suijing Wu, Xin Du, MD PhD, Jianyu Weng, MD

Blood (2018) 132 (Supplement 1): 5229.

https://doi.org/10.1182/blood-2018-99-116234

Published: 2018

Journal Articles

Artesunate Attenuate Chronic Graft-Versus-Host Disease By Regulating Th17/Treg Balance

Chen Xiaomei, Jianyu Weng, MD, Peilong Lai, Xin Huang, Wang Yulian, Suxia Geng, Liyan Guo, Tian Huang, Lingji Zeng, Xin Du, MD PhD

Blood (2018) 132 (Supplement 1): 5680.

https://doi.org/10.1182/blood-2018-99-114556

Published: 2018

Journal Articles

Comparison of the 5 Year Medical Outcome and Quality of Life of Patients with Chronic Myeloid Leukemia Treated with Imatinib or Allogeneic Transplant

Lisi Huang, Xin Du, Jianyu Weng, MD, Peilong Lai, Zesheng Lu, Ping Wu, Suijing Wu, PhD, Chengwei Luo, Xin Huang, Suxia Geng

Blood (2015) 126 (23): 2118.

https://doi.org/10.1182/blood.V126.23.2118.2118

Published: 2015

Journal Articles

A Clinical Study of Bone Marrow Stromal Cell Therapy in Patients with Refractory Cgvhd by Down-Regulating the Jagged2 Gene

Jianyu Weng, MD, Xin Huang, Suxia Geng, Chengwei Luo, Suijing Wu, Wei Ling, Rong Guo, Zesheng Lu, Chengxin Deng, Pengxiang Andy, Xin Du

Blood (2012) 120 (21): 4673.

https://doi.org/10.1182/blood.V120.21.4673.4673

Published: 2012

Journal Articles

Fludarabine, Cytarabine, Busulphan, and Cyclophosphamide (FABC) as Conditioning Regimen in Hematopoietic Stem Cell Transplantation for Treatment of 92 Patients with Hematologic Malignancies.

Jianyu Weng, MD, Xin Du, PhD, Suijin Wu, MD, Zesheng Lu, MD, Chengwei Luo, MD, Rong Guo, PhD, Liye Zhong, MD, Miaorong She, PhD, Chengxin Deng, Wei Ling, PhD, Xiaoli Zou, Qunhua Li, Wei Lin, Zhixin Huang

Blood (2009) 114 (22): 1147.

https://doi.org/10.1182/blood.V114.22.1147.1147

Published: 2009

Journal Articles

Different Dosage of Bortezomib Impacts the Prevention of Acute Graft-Versus-Host Disease.

Jianyu Weng, MD, Meikun Lü, MD, Xin Du, PhD, Lin Xu, PhD, Suxia Geng, MD, Rong Guo, PhD, Suijin Wu, MD, Wei Ling, PhD, Yuchun Wang

Blood (2009) 114 (22): 4499.

https://doi.org/10.1182/blood.V114.22.4499.4499

Published: 2009

Journal Articles

Mesenchymal Stem Cells Relieve Chronic GVHD Via Modulation the Ratio of CD8+CD28-/CD8+CD28+T Cells.

Jianyu Weng, MD, Xin Du, PhD, Suxia Geng, MD, Maohua Zhou, MD, Yanwen Peng, Zhen Wang, Zesheng Lu, Suijing Wu, MD, Chenwei Luo, MD, Rong Guo, PhD, Wei Ling, PhD, Chengxin Deng, Pengjun Liao, Andy Peng Xiang, Ph.D

Blood (2009) 114 (22): 4501.

https://doi.org/10.1182/blood.V114.22.4501.4501

Published: 2009

Journal Articles

Distribution of Cytoskeleton Protein Nestin in Acute Leukemia.

Xin Du, PhD, Xuhui Yang, PhD, Wei Ling, PhD, Xia Tian, Maoxian Zou, Zhengguang Chen, Tao Wang, Jianyu Weng, MD, Suijing Wu, MD, Rong Guo, PhD, Xiuming Zhang, Bruce T. Lahn, Andy Peng Xiang, PhD

Blood (2009) 114 (22): 4721.

https://doi.org/10.1182/blood.V114.22.4721.4721

Published: 2009

Journal Articles

Analysis of TCR Vgamma and Vdelta Repertoire and Clonality of T Cells in MDS Patients.

SuXia Geng, MD, Xin Du, PhD, Yangqiu Li, PhD, Jianyu Weng, MD, Liye Zhong, MD, Suijing Wu, MD, Rong Guo, PhD, Zesheng Lu, MD

Blood (2009) 114 (22): 4833.

https://doi.org/10.1182/blood.V114.22.4833.4833

Published: 2009

Journal Articles

Analysis of the Immunophenotypic Features of Blast Cells, Lymphocytes and Granulocytes by Multiparametric Flow Cytometry in Bone Marrow (BM) Cells of Myelodysplastic Syndromes.

Xin Du, PhD, Jing Huang, MD, Maohua Zhou, MD, SuXia Geng, MD, Jianyu Weng, MD, Suijing Wu, MD, Rong Guo, PhD, Zesheng Lu, MD, Miaorong She, PhD

Blood (2009) 114 (22): 4843.

https://doi.org/10.1182/blood.V114.22.4843.4843

Published: 2009

Journal Articles

Analysis of Clinical Characterization of CMML.

Suijing Wu, MD, Xin Du, PhD, Wei Lin, Zilun Huang, Jianyu Weng, MD, Zhixin Huang, Maohua Zhou, MD, Jianhua Su, Zesheng Lu

Blood (2009) 114 (22): 4853.

https://doi.org/10.1182/blood.V114.22.4853.4853

Published: 2009

Journal Articles

Elderly Acute Myeloid Leukemia: A Retrospective Analysis of 93 Cases.

Xin Du, PhD, Yuchun Wang, Zesheng Lu, MD, Jianyu Weng, MD, Xiaoli Zou

Blood (2009) 114 (22): 4163.

https://doi.org/10.1182/blood.V114.22.4163.4163

Published: 2009

Journal Articles

Expression and Clinical Significance of Antiapoptotic Gene Aven in De Novo acute Myeloid Leukemia Patients.

SuXia Geng, MD, Xin Du, PhD/MD, Jianyu Weng, MD, Liye Zhong, MD, Rong Guo, PhD, Zesheng Lu, MD, Suijing Wu, MD

Blood (2009) 114 (22): 4132.

https://doi.org/10.1182/blood.V114.22.4132.4132

Published: 2009

Journal Articles

Using Multiparametric Flow Cytometry to Analysis the Immunophenotypic Abnormalities of Bone Marrow Cells in Patients with MDS-RAEB.

Jing Huang, MD, Xin Du, PhD, Suxia Geng, MD, Maohua Zhou, MD, Jianyu Weng, MD, Suijing Wu, MD, Rong Guo, PhD, Zesheng Lu, MD, Miaorong She, PhD

Blood (2009) 114 (22): 4856.

https://doi.org/10.1182/blood.V114.22.4856.4856

Published: 2009

Journal Articles

Phosphoinositide-3-Kinase Plays a Vital Role in Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cells Transplantation

Haizhou Xing, MD, Xin Du, PhD/MD, Jianyu Weng, MD, Zesheng Lu, MD

Blood (2008) 112 (11): 4363.

https://doi.org/10.1182/blood.V112.11.4363.4363

Published: 2008

Journal Articles

Mesenchymal Stem Cells Derived from Different Donors as Salvage Therapy for Resistant Severe Acute Graft-Versus-Host Disease

Jianyu Weng, MD, Xin Du, PhD/MD, Peng Xiang, PhD, Suijin Wu, MD, Zesheng Lu, MD, Chengwei Luo, MD, Rong Guo, MD, Wei Ling, MD

Blood (2008) 112 (11): 4364.

https://doi.org/10.1182/blood.V112.11.4364.4364

Published: 2008

Journal Articles

Serum Proteome Profiling Detects Myelodysplastic Syndromes and Different Expression of Fibrinogen Between RAEB and RCMD

Liye Zhong, MD, TianHao Liu, MD, SuXia Geng, MD, Zesheng Lu, MD, Jianyu Weng, MD, Xin Du, PhD/MD

Blood (2008) 112 (11): 5082.

https://doi.org/10.1182/blood.V112.11.5082.5082

Published: 2008

Journal Articles

Retrospective Comparison of Lymphocyte Subsets in the Different Stage of Patients with Chronic Graft-Versus-Host Disease after HSCT for Possibility of Early Diagnosis.

Haizhou Xing, MD, Xin Du, MD, PhD, Jianyu Weng, MD, Zesheng Lu, MD, Jianjun Zhang, MD, Maohua Zhou, MD

Blood (2007) 110 (11): 4967.

https://doi.org/10.1182/blood.V110.11.4967.4967

Published: 2007

Journal Articles

A Pilot Study of Mycophenolate Mofetil for the Prophylaxis and Treatment of Graft-Versus-Host Disease.

Chengwei Luo, MD, Xin Du, MD, PhD, Jianyu Weng, MD, Rong Guo, MD, Zesheng Lu, MD

Blood (2007) 110 (11): 4969.

https://doi.org/10.1182/blood.V110.11.4969.4969

Published: 2007

NARROW

Dasatinib Versus Imatinib in Patients (Pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Who Have Not Achieved an Optimal Response to 3 Months of Imatinib Therapy: Dascern

Compared the Effect of Mitroxantrone ( MA) with Idarubicine (IA) for Acute Myeloid Leukemia Induction Therapy

Artesunate Attenuate Chronic Graft-Versus-Host Disease By Regulating Th17/Treg Balance

Comparison of the 5 Year Medical Outcome and Quality of Life of Patients with Chronic Myeloid Leukemia Treated with Imatinib or Allogeneic Transplant

A Clinical Study of Bone Marrow Stromal Cell Therapy in Patients with Refractory Cgvhd by Down-Regulating the Jagged2 Gene

Fludarabine, Cytarabine, Busulphan, and Cyclophosphamide (FABC) as Conditioning Regimen in Hematopoietic Stem Cell Transplantation for Treatment of 92 Patients with Hematologic Malignancies.

Different Dosage of Bortezomib Impacts the Prevention of Acute Graft-Versus-Host Disease.

Mesenchymal Stem Cells Relieve Chronic GVHD Via Modulation the Ratio of CD8+CD28-/CD8+CD28+T Cells.

Distribution of Cytoskeleton Protein Nestin in Acute Leukemia.

Analysis of TCR Vgamma and Vdelta Repertoire and Clonality of T Cells in MDS Patients.

Analysis of the Immunophenotypic Features of Blast Cells, Lymphocytes and Granulocytes by Multiparametric Flow Cytometry in Bone Marrow (BM) Cells of Myelodysplastic Syndromes.

Analysis of Clinical Characterization of CMML.

Elderly Acute Myeloid Leukemia: A Retrospective Analysis of 93 Cases.

Expression and Clinical Significance of Antiapoptotic Gene Aven in De Novo acute Myeloid Leukemia Patients.

Using Multiparametric Flow Cytometry to Analysis the Immunophenotypic Abnormalities of Bone Marrow Cells in Patients with MDS-RAEB.

Phosphoinositide-3-Kinase Plays a Vital Role in Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cells Transplantation

Mesenchymal Stem Cells Derived from Different Donors as Salvage Therapy for Resistant Severe Acute Graft-Versus-Host Disease

Serum Proteome Profiling Detects Myelodysplastic Syndromes and Different Expression of Fibrinogen Between RAEB and RCMD

Retrospective Comparison of Lymphocyte Subsets in the Different Stage of Patients with Chronic Graft-Versus-Host Disease after HSCT for Possibility of Early Diagnosis.

A Pilot Study of Mycophenolate Mofetil for the Prophylaxis and Treatment of Graft-Versus-Host Disease.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only